Products for Research Use Only
RegisterLogin

BLXA-4-ME

CAT: 0804-HY-123642Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-123642Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BLXA-4-ME is used for gingivitis study[1].
CAS Number
362516-29-8
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/blxa-4-me.html
Solubility
10 mM in DMSO
Smiles
O=C(CCC[C@@H]([C@@H](/C=C/C1=CC=CC=C1/C=C/[C@@H](CCCCC)O)O)O)OC
Molecular Formula
C23H34O5
Molecular Weight
390.51
References & Citations
[1]Ting Fu, et al. Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease. ACS Pharmacol Transl Sci (Report missing IFs) . 2020 Jan 17;3 (1) :43-55.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-169375RSL3-4-Me
HY-W8677044-Me-Thalidomide
HY-W013522Me-PEG4-Me
HY-W013522R-01Me-PEG4-Me (Standard)
HY-N3328Malic acid 4-Me ester
HY-W460193-01N-Me-Thalidomide 4-fluoride
HY-W016031Fmoc-Phe (4-Me) -OH
HY-W441376-01Thalidomide-1-Me,4-OH
HY-W042007-01H-D-Phe (4-Me) -OH
HY-W042001-01H-DL-Phe (4-Me) -OH

Alternative Products

CatalogName
T26838-01BLXA-4
GTR19210214-014-Me-PDTic
GTR19258552-014-Me-Thalidomide
T69798-014-Me-PDTic HCl
CSB-DT2682(2S, 3R) -Fmoc-β-Me-4- (Me) -Phe-OH
MBS9023174-01(2S, 3R)-Fmoc-beta-Me-4-(Me)-Phe-OH
TN4487Malic acid 4-Me ester
5-04075Boc-Phe(4-Me)-OH
5-04081Fmoc-Phe(4-Me)-OH
sc-228214Fmoc-Phe (4-Me) -OH

Popular Products